Introducing Thyroid GuidePx®

Helping guide your papillary thyroid cancer treatment journey!

Learn More

Our Team

Our Team

Chief Executive Officer

Oliver Bathe MD, FRCSC, FACS
Chief Scientific Officer

Cynthia Stretch PhD
Chief Technology Officer

Dave Ehman P.Eng., CISSP
Chief Operating Officer

Jeff Blacklock P.Eng., MBA
Director of Compliance

Sally Abou-Zeki MBA, MLT, MLS(ASCP)CM
Chief Executive Officer

Oliver Bathe MD, FRCSC, FACS

Oliver Bathe, MD is a surgical oncologist with over 25 years of clinical experience. As a result, he has an excellent understanding of the challenges that patients and clinicians face during their Cancer Journey. He is a professor of Surgery and Oncology at the University of Calgary. His research has mostly been translational in nature, applying cutting edge technological solutions to real clinical problems. In 2004, Bathe founded a large tumor bank that currently houses over 23,000 samples from over 4,000 patients. His involvement in The Cancer Genome Atlas Project (TCGA) and his leadership in the Clinical Proteomic Analysis Consortium (CPTAC) have spurred his interest in systems biology and bioinformatics. He also has experience in clinical trials, serving in leadership positions on several national and international clinical trial groups. He has directed a research program, attracting over $2 million to research related to several technologies, the majority of which have been transferred to Qualisure.

Chief Scientific Officer

Cynthia Stretch PhD

Cynthia Stretch, PhD is a cancer biologist with over 14 years of experience using omic technologies in wet and dry laboratory settings. She completed her PhD in the Department of Oncology at the University of Alberta where she developed her expertise in metabolomics, transcriptomics and computational biology. Stretch has been working with Bathe since 2015. Her postdoctoral work at the University of Calgary’s Arnie Charbonneau Cancer Institute is focused on integrating genomic, epigenomic, transcriptomic and proteomic data from the tumor to better understand the host response.

Chief Technology Officer

Dave Ehman P.Eng., CISSP

Dave Ehman P.Eng., CISSP is a technology, engineering, operations, and security expert with over 20 years of experience designing, building, and operating critical infrastructure around the world, including Canada, Singapore, and Australia. Dave has served as Chief Technology Officer, Chief Engineer, and Vice President at a variety of publicly traded and privately held companies. He brings an extremely broad technology background, deep technical knowledge, and strong systems engineering approach to the team. He has served in senior technology leadership roles in a wide variety of industries, including Security, Construction, Networks, Electric Utilities, Government Regulation, Privacy, and Defense/Aerospace. Dave is a Professional Engineer (P.Eng.), and a member of APEGA with a Permit to Practice. He holds a B.A.Sc. degree in Electronic Information Systems Engineering from the University of Regina and a Certified Information Systems Security Professional (“CISSP”) designation from ISC2.

Chief Operating Officer

Jeff Blacklock P.Eng., MBA

Jeff has spent his career engaging in companies that have experienced fast paced growth, market volatility, and transition. He has multiple successes scaling, repositioning and transitioning companies. His strength is in bringing order to chaos. With both a technical and management back ground, he has the ability to understand how businesses and products work on a detailed scale, and merge those details with business and financial strategies to drive success. He is big believer in teamwork, and in facilitating a culture and environment of transparency and accountability.

Director of Compliance

Sally Abou-Zeki MBA, MLT, MLS(ASCP)CM

Sally Abou-Zeki, MBA is a quality, regulatory, accreditation, and operations professional with project management skills in designing, implementing, and maintaining quality management systems. Sally holds an MBA degree in Project Management from the University of Calgary, and is an experienced medical laboratory technologist holding MLT and MLS (ASCP) practice certifications. Sally has served on Council, Finance, and Legislation committees for the College of Medical Laboratory Science of Alberta as general council, Vice President, and President. She brings a wealth of knowledge on industry standards for clinical test development, and on navigating government regulation to bring medical devices to market.

Our Partners

Protean BioDiagnostics is a clinical laboratory in Orlando, Florida specializing in precision cancer diagnostics.